查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1745747

路易氏體失智症治療的全球市場:市場規模·佔有率·趨勢，產業分析 (藥物類別·各適應症·各流通管道·各地區)，未來預測 (2025年～2034年)

Lewy Body Dementia Treatment Market Size, Share, Trends, Industry Analysis Report: By Drug Type, Indication, Distribution Channel, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 112 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，預計到 2034 年，全球路易氏體失智症治療市場規模將達到 133.2 億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

路易氏體失智症治療市場專注於旨在控制路易氏體失智症 (LBD) 相關症狀的醫療治療和介入措施。路易氏體失智症是一種由腦內異常蛋白質沉積引起的進行性神經退化性疾病。路易氏體失智症表現為認知能力下降、運動障礙、精神症狀和自主神經功能障礙，需要藥物治療和非藥物治療相結合。膽鹼酯酶抑制劑、卡比多巴-左旋多巴以及劑量精準的抗精神病藥物等藥物療法被廣泛使用，而物理和認知復健等支持療法在症狀管理中也發揮著重要作用。

由於全球人口老化、神經退化性疾病盛行率上升以及診斷工具的進步提高了早期檢測率，路易氏體失智症治療市場正在不斷增長。製藥公司正在加大研發投入，臨床試驗也正在探索新的候選藥物，以提高治療效果。此外，政府對失智症研究的投入和資金不斷增加，以及醫療成本的不斷上漲，也為路易氏體失智症治療市場創造了龐大的商機。數位醫療解決方案、遠距醫療和個人化醫療等趨勢正在進一步塑造市場格局。此外，預計主要公司之間的持續創新和合作將推動市場持續成長。

路易氏體失智症治療市場：分析概述

  • 2024年，路易氏體失智症治療市場的佔有率主要由膽鹼酯酶抑制劑佔據。這些藥物包括多奈哌齊、利凡斯的明和加蘭他敏，透過抑制一種名為膽鹼酯酶的酵素來發揮作用，從而增加大腦中乙醯膽鹼的濃度。
  • 2024年，帕金森氏症將佔據市場主導地位，因為它與路易氏體失智症的病理學重疊，這將增加對有效治療這兩種神經退化性疾病的治療方案的需求。
  • 按地區劃分，北美佔據路易氏體失智症治療市場的最大佔有率，這主要歸功於其龐大的患者群體、日益增強的認知度以及先進的醫療基礎設施。
  • 在路易氏體失智症治療市場中，一些關鍵參與者正在積極推動治療方案的進步。這些公司包括衛材、諾華、輝瑞、葛蘭素史克、羅氏、默克、強生、賽諾菲、艾伯維、阿斯特捷利康、百時美施貴寶、禮來公司、武田製藥、優時比公司和大塚製藥。

目錄

第1章 簡介

第2章 摘要整理

第3章 分析方法

第4章 全球路易氏體失智症治療市場洞察

  • 市場概述
  • 路易氏體失智症治療的市場動態
    • 促進因素和機會
      • 路易氏體失智症盛行率不斷上升
      • 研究與臨床試驗的進展
    • 阻礙因素與課題
      • 缺乏有效的疾病改良療法
  • 大環境分析
  • 路易氏體失智症治療市場有效利用趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球路易氏體失智症治療市場:藥物類別

  • 主要的分析結果
  • 簡介
  • 莫達非尼
  • 膽鹼酯酶抑制劑
  • 苯二氮平類藥物
  • 抗精神病藥
  • 抗憂鬱藥
  • 卡比多巴/左旋多巴

第6章 全球路易氏體失智症治療市場:各適應症

  • 主要的分析結果
  • 簡介
  • 帕金森氏症
  • 路易氏體失智症(DLB)

第7章 全球路易氏體失智症治療市場:各流通管道

  • 主要的分析結果
  • 簡介
  • 藥妝店
  • 醫院藥局
  • 線上藥局
  • 零售藥局

第8章 全球路易氏體失智症治療市場:各地區

  • 主要的分析結果
  • 簡介
    • 路易氏體失智症治療市場分析:各地區 (2020～2034年)
  • 北美
    • 北美:藥物類別(2020～2034年)
    • 北美:各適應症(2020～2034年)
    • 北美:各流通管道(2020～2034年)
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:藥物類別(2020～2034年)
    • 歐洲:各適應症(2020～2034年)
    • 歐洲:各流通管道(2020～2034年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:藥物類別(2020～2034年)
    • 亞太地區:各適應症(2020～2034年)
    • 亞太地區:各流通管道(2020～2034年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:藥物類別(2020～2034年)
    • 中東·非洲:各適應症(2020～2034年)
    • 中東·非洲:各流通管道(2020～2034年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:藥物類別(2020～2034年)
    • 南美:各適應症(2020～2034年)
    • 南美:各流通管道(2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第9章 競爭情形

  • 事業擴大·企業收購的分析
    • 事業擴大
    • 企業收購
  • 聯盟/合作/協定/公開

第10章 企業簡介

  • AbbVie Inc.
  • AstraZeneca plc
  • Bristol-Myers Squibb Company
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
Product Code: PM1742

The global Lewy body dementia treatment market size is expected to reach USD 13.32 billion by 2034, according to a new study by Polaris Market Research. The report "Lewy Body Dementia Treatment Market Size, Share, Trends, Industry Analysis Report: By Drug Type (Modafinil, Cholinesterase Inhibitors, Benzodiazepine, Antipsychotic Drugs, Antidepressants, and Carbidopa-Levodopa), Indication, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Lewy body dementia treatment market focuses on medical therapies and interventions aimed at managing symptoms associated with Lewy body dementia (LBD), a progressive neurodegenerative disorder caused by abnormal protein deposits in the brain. LBD presents with cognitive decline, movement impairments, psychiatric symptoms, and autonomic dysfunction, requiring a combination of pharmacological and non-pharmacological treatments. Medications such as cholinesterase inhibitors, carbidopa-levodopa, and carefully administered antipsychotics are commonly used, while supportive therapies like physical and cognitive rehabilitation play a crucial role in symptom management.

The market is experiencing growth due to an aging global population, increasing prevalence of neurodegenerative diseases, and advancements in diagnostic tools improving early detection. Pharmaceutical companies are investing in research and development, with clinical trials exploring novel drug candidates to enhance treatment efficacy. Additionally, increasing government initiatives and funding for dementia research, coupled with rising healthcare expenditure, create significant Lewy body dementia treatment market opportunities. Trends such as digital health solutions, telemedicine, and personalized medicine are further shaping the market landscape. Furthermore, ongoing innovations and collaborations among key players are expected to drive sustained growth.

Lewy Body Dementia Treatment Market Report Highlights

  • Cholinesterase inhibitors dominated the Lewy body dementia treatment market share in 2024. These medications, including donepezil, rivastigmine, and galantamine, function by inhibiting the enzyme cholinesterase, thereby increasing acetylcholine levels in the brain.
  • In 2024, the Parkinson's disease segment dominated the market due to its overlapping pathology with Lewy body dementia, driving increased demand for treatments that address both neurodegenerative conditions effectively.
  • By region, North America held the largest share in the Lewy body dementia treatment market, primarily due to a significant patient population, increased awareness, and the availability of advanced healthcare infrastructure.
  • In the Lewy body dementia treatment market, several key players are actively contributing to advancements in therapeutic options. These companies include Eisai Co., Ltd.; Novartis AG; Pfizer Inc.; GlaxoSmithKline plc; F. Hoffmann-La Roche Ltd; Merck & Co., Inc.; Johnson & Johnson; Sanofi S.A.; AbbVie Inc.; AstraZeneca plc; Bristol-Myers Squibb Company; Eli Lilly and Company; Takeda Pharmaceutical Company Limited; UCB S.A.; and Otsuka Pharmaceutical Co., Ltd.

Polaris Market Research has segmented the Lewy body dementia treatment market report on the basis of drug type, indication, distribution channel, and region:

By Drug Type Outlook (Revenue - USD Billion, 2020-2034)

  • Modafinil
  • Cholinesterase Inhibitors
  • Benzodiazepine
  • Antipsychotic Drugs
  • Antidepressants
  • Carbidopa-Levodopa

By Indication Outlook (Revenue - USD Billion, 2020-2034)

  • Parkinson's Disease
  • Dementia with Lewy Bodies (DLB)

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

  • Drug Stores
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Lewy Body Dementia Treatment Market Insights

  • 4.1. Lewy Body Dementia Treatment Market - Market Snapshot
  • 4.2. Lewy Body Dementia Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of Lewy body dementia
      • 4.2.1.2. Advancements in research and clinical trials
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Lack of effective disease-modifying therapies
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Lewy Body Dementia Treatment Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Lewy Body Dementia Treatment Market, by Drug Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • 5.3. Modafinil
    • 5.3.1. Global Lewy Body Dementia Treatment Market, by Modafinil, by Region, 2020-2034 (USD Billion)
  • 5.4. Cholinesterase Inhibitors
    • 5.4.1. Global Lewy Body Dementia Treatment Market, by Cholinesterase Inhibitors, by Region, 2020-2034 (USD Billion)
  • 5.5. Benzodiazepine
    • 5.5.1. Global Lewy Body Dementia Treatment Market, by Benzodiazepine, by Region, 2020-2034 (USD Billion)
  • 5.6. Antipsychotic Drugs
    • 5.6.1. Global Lewy Body Dementia Treatment Market, by Antipsychotic Drugs, by Region, 2020-2034 (USD Billion)
  • 5.7. Antidepressants
    • 5.7.1. Global Lewy Body Dementia Treatment Market, by Antidepressants, by Region, 2020-2034 (USD Billion)
  • 5.8. Carbidopa-Levodopa
    • 5.8.1. Global Lewy Body Dementia Treatment Market, by Carbidopa-Levodopa, by Region, 2020-2034 (USD Billion)

6. Global Lewy Body Dementia Treatment Market, by Indication

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • 6.3. Parkinson's Disease
    • 6.3.1. Global Lewy Body Dementia Treatment Market, by Parkinson's Disease, by Region, 2020-2034 (USD Billion)
  • 6.4. Dementia with Lewy Bodies (DLB)
    • 6.4.1. Global Lewy Body Dementia Treatment Market, by Dementia with Lewy Bodies (DLB), by Region, 2020-2034 (USD Billion)

7. Global Lewy Body Dementia Treatment Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.3. Drug Stores
    • 7.3.1. Global Lewy Body Dementia Treatment Market, by Drug Stores, by Region, 2020-2034 (USD Billion)
  • 7.4. Hospitals Pharmacies
    • 7.4.1. Global Lewy Body Dementia Treatment Market, by Hospitals Pharmacies, by Region, 2020-2034 (USD Billion)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Lewy Body Dementia Treatment Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)
  • 7.6. Retail Pharmacies
    • 7.6.1. Global Lewy Body Dementia Treatment Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)

8. Global Lewy Body Dementia Treatment Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Lewy Body Dementia Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Lewy Body Dementia Treatment Market - North America
    • 8.3.1. North America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
    • 8.3.3. North America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.4. Lewy Body Dementia Treatment Market - U.S.
      • 8.3.4.1. U.S.: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.5. Lewy Body Dementia Treatment Market - Canada
      • 8.3.5.1. Canada: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.4. Lewy Body Dementia Treatment Market - Europe
    • 8.4.1. Europe: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.4. Lewy Body Dementia Treatment Market - UK
      • 8.4.4.1. UK: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.5. Lewy Body Dementia Treatment Market - France
      • 8.4.5.1. France: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.6. Lewy Body Dementia Treatment Market - Germany
      • 8.4.6.1. Germany: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.7. Lewy Body Dementia Treatment Market - Italy
      • 8.4.7.1. Italy: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.8. Lewy Body Dementia Treatment Market - Spain
      • 8.4.8.1. Spain: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.9. Lewy Body Dementia Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.10. Lewy Body Dementia Treatment Market - Russia
      • 8.4.10.1. Russia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.11. Lewy Body Dementia Treatment Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.5. Lewy Body Dementia Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.4. Lewy Body Dementia Treatment Market - China
      • 8.5.4.1. China: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.5. Lewy Body Dementia Treatment Market - India
      • 8.5.5.1. India: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.6. Lewy Body Dementia Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.7. Lewy Body Dementia Treatment Market - Japan
      • 8.5.7.1. Japan: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.8. Lewy Body Dementia Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.9. Lewy Body Dementia Treatment Market - South Korea
      • 8.5.9.1. South Korea: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.10. Lewy Body Dementia Treatment Market - Australia
      • 8.5.10.1. Australia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.11. Lewy Body Dementia Treatment Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.6. Lewy Body Dementia Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.4. Lewy Body Dementia Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.5. Lewy Body Dementia Treatment Market - UAE
      • 8.6.5.1. UAE: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.6. Lewy Body Dementia Treatment Market - Israel
      • 8.6.6.1. Israel: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.7. Lewy Body Dementia Treatment Market - South Africa
      • 8.6.7.1. South Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.8. Lewy Body Dementia Treatment Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.7. Lewy Body Dementia Treatment Market - Latin America
    • 8.7.1. Latin America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.4. Lewy Body Dementia Treatment Market - Mexico
      • 8.7.4.1. Mexico: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.5. Lewy Body Dementia Treatment Market - Brazil
      • 8.7.5.1. Brazil: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.6. Lewy Body Dementia Treatment Market - Argentina
      • 8.7.6.1. Argentina: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.7. Lewy Body Dementia Treatment Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. AstraZeneca plc
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bristol-Myers Squibb Company
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Eisai Co., Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Eli Lilly and Company
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. F. Hoffmann-La Roche Ltd
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. GlaxoSmithKline plc
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Johnson & Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Merck & Co., Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Novartis AG
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 2 Global Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 3 Global Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 4 North America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 5 North America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 6 North America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 7 U.S.: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 9 U.S.: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 10 Canada: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 12 Canada: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 13 Europe: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 15 Europe: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 16 UK: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 17 UK: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 18 UK: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 19 France: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 20 France: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 21 France: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 22 Germany: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 24 Germany: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 25 Italy: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 27 Italy: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 28 Spain: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 30 Spain: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 34 Russia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 36 Russia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 43 China: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 44 China: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 45 China: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 46 India: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 47 India: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 48 India: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 52 Japan: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 54 Japan: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 58 South Korea: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 60 South Korea: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 61 Australia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 63 Australia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 73 UAE: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 75 UAE: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 76 Israel: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 78 Israel: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 79 South Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 81 South Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 85 Latin America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 87 Latin America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 88 Mexico: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 90 Mexico: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 91 Brazil: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 93 Brazil: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 94 Argentina: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 96 Argentina: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Lewy Body Dementia Treatment Market, by Drug Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Lewy Body Dementia Treatment Market, by Indication, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Lewy Body Dementia Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Lewy Body Dementia Treatment Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Drug Type
  • Figure 7. Global Lewy Body Dementia Treatment Market, by Drug Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Indication
  • Figure 9. Global Lewy Body Dementia Treatment Market, by Indication, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Lewy Body Dementia Treatment Market, by Distribution Channel, 2024 & 2034 (USD Billion)